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ABSTRACT
CHRISTOPHER CAMPBELL DORROH: Investigating the Impact of AGE/RAGE
Signaling on Oxidative Stress Under Diabetic Conditions in Cardiac Fibroblasts
(Under the direction of Dr. James A. Stewart, Jr.)
Diabetes is a major health concern in the United States, with 1.5 million new
cases diagnosed each year. Patients who suffer from diabetes have an increased risk of
developing heart failure, a form of cardiovascular disease. Heart failure has been shown
to result from increased left ventricular stiffness, which in turn is caused by increased
remodeling of the extracellular matrix (ECM). This increase in ECM remodeling is a
result of AGE/RAGE signaling, which occurs at a heightened level in the cardiac
fibroblast cells of diabetics. Studies have shown that diabetics have elevated levels of
AGEs (Advanced Glycation End-Products), which bind to RAGEs (Receptors for
Advanced Glycation End-Products) on the cell surface, causing AGE/RAGE signaling to
occur. AGE/RAGE signaling has also been demonstrated to play a role in oxidative
stress. In addition to heart muscle stiffening, oxidative stress in the myocardium has also
been found to correlate with left ventricular dysfunction. In this study we examined the
impact of AGE/RAGE signaling on the relative expression levels of three different
proteins associated with oxidative stress: p-NF-κB, SOD-1, and SOD-2. To accomplish
this, we isolated cardiac fibroblasts from mice of six different genotypes: non-diabetic,
diabetic, non-diabetic RAGE knockout, diabetic RAGE knockout, Rap1a wildtype, and
Rap1a knockout. After isolation, we then grew those cells on plates that either had no
underlying collagen (plastic), non-diabetic collagen (low endogenous AGEs), or diabetic
collagen (elevated endogenous AGEs). We also treated some groups of fibroblasts with
the pharmacological modifier EPAC, an allosteric activator of the enzyme Rap1a, to
further alter the level of AGE/RAGE signaling. After treatment, proteins were isolated to
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assess changes in the expression of oxidative stress markers via western blot analysis.
Recently, research in our lab has identified that Rap1a, a small GTPase, may bisect the
AGE/RAGE signaling pathway and contribute to the downstream outcomes. In light of
this new data, we were also interested in assessing the impact of Rap1a on the
AGE/RAGE-driven oxidative stress response. We found that increasing AGE/RAGE
signaling led to an increase in expression of p-NF-κB and a decrease in expression of
SOD-1 and SOD-2. In addition, we found that Rap1a appears to play an important role in
the AGE/RAGE cascade by augmenting the downstream effects of this signaling
pathway.
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CHAPTER I
INTRODUCTION
Diabetes Mellitus
Diabetes Mellitus (DM) refers to a group of related diseases. People with diabetes
have persistently elevated blood glucose levels caused by deficiencies in insulin
production or insulin signaling.1 Insulin is a peptide hormone secreted by cells of the
pancreas that causes increased cellular glucose uptake, thereby lowering the sugar
concentration in the blood.2 Without the presence or proper functioning of this endocrine
signal, blood sugar homeostasis is disrupted, causing glucose levels in the blood to rise
unchecked. There are many symptoms associated with diabetes. Glucose is an
osmotically active particle, so high levels of glucose in the filtrate of the nephron results
in large volumes of fluid being drawn into it. As a result, people with diabetes frequently
experience increased urination (polyuria) and increased thirst (polydipsia). Left untreated,
patients with diabetes are at high risk of developing severe long-term health problems,
such as damage to the retinas of the eyes, kidney failure, impairment of the autonomic
nervous system, peripheral neuropathy, and open sores on the lower extremities that can
require amputation of limbs.1 Patients with diabetes also experience atherosclerosis,
hypertension, and other vascular pathologies at higher rates.1 There are two main types of
diabetes. Type 1 diabetes, also known as juvenile-onset diabetes, is a less common form
of the disease that makes up 5-10% of diabetes cases.1 Type 1 DM is caused by
autoimmune destruction of the β-cells of the pancreas, which produce the insulin
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hormone.3 Without the ability to endogenously produce insulin, glucose levels in the
blood rise without control. Type 2 diabetes, also known as adult-onset diabetes, is the
more common form of the disease, making up about 90-95% of diabetes cases.1 People
with type 2 diabetes have reduced sensitivity to insulin, as well as insulin deficiency.1
Diabetes is a major global public health crisis. According to 2019 data from the
International Diabetes Federation, 463 million people around the world live with the
disease.4 The number of people living with diabetes is increasing rapidly, and it is
expected to rise to 578 million by 2030, and 700 million by 2045.4

Cardiac Fibroblasts
Heart tissue is made up of several different cell types, which include myocytes,
endothelial cells, vascular smooth muscle cells, neurons, and fibroblasts. Of these,
cardiac fibroblasts are the most numerous cell population in the heart, making up to 70%
of the total number of cells.5,6 Fibroblasts are a permanent cell population in the heart
derived from mesenchymal embryonic tissue, and they are important in maintaining the
structure of the heart tissue through their continual remodeling of the extracellular
matrix.7 These cells carry out this task by synthesizing and depositing fibrous structural
proteins, such as collagen and fibronectin, into the extracellular space.8 In addition,
cardiac fibroblasts also produce enzymes that degrade and turnover the extracellular
matrix, allowing for flexible myocardial remodeling.8 Fibroblasts have a distinctive
morphology. They are spindle-shaped cells with cytoplasmic processes that radiate
outward from the cell body. Fibroblasts are also important in repair of damaged heart
tissue after a myocardial infarction (MI). Following a MI, cardiac fibroblasts are able to
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differentiate into a myofibroblast phenotype. Myofibroblasts have greater contractility
and secretory ability than the undifferentiated form.6 In addition, they are able to
proliferate at a higher rate. These characteristics facilitate the myofibroblasts as they
carry out their role in repairing infarcted areas of the heart.

The AGE/RAGE Signaling Cascade
Proteins and lipids circulating in the blood coexist in this environment with
sugars. When proteins and lipids come into close contact with aldose sugars, there is a
chance they will form covalent attachments through nonenzymatic reactions. Glycation
of proteins occurs when the N-terminus of a protein carries out a nucleophilic attack on
the electrophilic carbonyl group of an aldose sugar to form a Schiff base.9 This transient
species may then rearrange to form an Amadori product.9 Subsequent irreversible
reactions lead to AGE formation.9 AGE formation is a natural process that occurs in nondiabetics; however, AGEs form at a higher rate in diabetics due to hyperglycemia.10,11
AGEs are able to exert diverse effects on cells by binding to receptors for advanced
glycation end products (RAGEs). RAGE is a transmembrane immunoglobulin receptor
that is capable of binding with a number of different ligands.12,13 AGE/RAGE signaling
leads to numerous downstream effects, such as increased secretion of profibrotic growth
factors, increased collagen deposition in the extracellular space, inflammation, and
increased expression of RAGE.14,15 The resulting increase of structural proteins in the
extracellular matrix, or fibrosis, causes stiffening of the left ventricle of the heart.14,15
This stiffening reduces the efficiency of the heart in pumping blood. RAGE activation
also contributes to oxidative stress, inflammation, and cell apoptosis.16 AGE/RAGE
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interaction contributes to oxidative stress through the activation of NADPH oxidase
(nicotinamide adenine dinucleotide phosphate oxidase) pathway.17 This enzyme catalyzes
the formation of superoxide radicals from NADPH and oxygen.18 Activation of this
enzyme without a proportionate increase in dismutase enzymes to dismantle the radicals
will therefore lead to oxidative stress. RAGE expression is also tied to the presence of
reactive oxygen species. RAGE expression has been found to occur at increased levels in
pancreatic cancer cells in response to the presence of reactive oxygen species in the
environment.19

Oxidative Stress
Reactive oxygen species (ROS) are unstable, oxygen-containing molecules that
include superoxides, hydroxyl radicals, hydrogen peroxide, hypochlorous acid, lipid
peroxides, hypochlorite, and singlet oxygen.20,21 These species are generated during the
normal course of metabolism.20 Despite their instability, reactive oxygen species are
essential to many physiological processes, such as cell signaling and immune defense.21
For example, some phagocytic leukocytes use superoxide as a bactericidal agent.22 It has
also been proposed that superoxide and other oxygen radicals may be important in the
antitumor and antimicrobial activities of macrophages, based on the observation that
superoxide anion production is greatly elevated in activated macrophages.23 In addition to
their generation by cells of the immune system, superoxide radicals are also created by
cells during the processes of aerobic metabolism, arachidonic acid metabolism, and as a
result of NADH and NADPH oxidase activity.20,24 High levels of reactive oxygen species
can have deleterious effects. In particular, reactive oxygen species can cause oxidative
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damage to the components of the electron transport chain, as well as important
macromolecules like DNA, proteins, and lipids.25,26 Oxidative stress occurs when the
generation of reactive oxygen species exceeds the ability of antioxidant enzymes to
dismantle those high-energy molecules. Mounting evidence implicates oxidative stress in
a number of different human diseases, including cancer, diabetes, hyperlipidemia,
ischemic heart disease, hypertension, and heart failure.27 In addition, high levels of
oxidative stress can cause cell apoptosis.19

Figure 1: The NADPH Oxidase System. Hyperglycemic conditions cause assembly of
the NADPH oxidase system. The enzyme complex catalyzes an oxidation-reduction
reaction in which cytosolic NADPH is oxidized while two molecules of oxygen outside
the cell are reduced to form superoxide radicals. The superoxide radicals may then
contribute to inflammation, oxidative stress, and fibrosis.

Hyperglycemia is a major cause of oxidative stress in certain cells of the body.
Hyperglycemia-induced oxidative stress occurs through an indirect mechanism that is
related to the inability of some cells to regulate their uptake of glucose. While most cells
of the body are able to regulate the level of glucose taken in, others are less able to
control their intracellular glucose concentrations. These include the cells of the renal
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glomeruli, the capillary endothelial cells of the eyes’ retinas, and nerve and glial cells in
the peripheral nervous system.28,29 The hyperglycemic environment in the cytosol of
these cells results in abnormally high production of the reduced electron carriers NADH
and FADH2 through the metabolic processes of glycolysis and the citric acid cycle.30
When these reduced electron carriers pass their electrons to the complexes of the electron
transport chain, electron transport becomes blocked at complex III as a result of the
abnormally large electromotive force generated across the inner mitochondrial
membrane.31 The increased lifespan of ubiquinol means there is a chance that this
coenzyme will reduce singlet oxygen to form the superoxide radical.31 The increased
production of reactive oxygen species associated with this process contributes to
oxidative stress.

Superoxide Dismutases
Superoxide dismutases (SODs) are important antioxidant enzymes that catalyze
the disproportionation (simultaneous oxidation and reduction) of superoxide radicals to
form hydrogen peroxide and molecular oxygen.32,33 Other enzymes, such as catalase and
glutathione peroxidase, will then convert the hydrogen peroxide to water and molecular
oxygen to protect the cell from oxidative damage.34,35 Underscoring the importance of the
SODs is their extreme efficiency: they have truly enormous catalytic efficiencies (ratios
of kcat/KM).36 This means they are able to catalyze a large number of dismutation reactions
per second, and the rate of catalysis is described as “diffusion limited.” There are three
SOD isozymes in humans that differ in structure, metal cofactor, and cellular
compartment in which they are found. SOD-1 is a 32 kDa dimer composed of two
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identical subunits, with copper and zinc metal cofactors in each subunit.37 These
cofactors are critical in carrying out the disproportionation reaction.37 SOD-1 is found
mostly in the cytosol.38,39 It is also found in the nucleus and the intermembrane space of
the mitochondrion.40 SOD-2 is found within the mitochondrial matrix, which is the
location of most free radical production in the cell due to electron transport chain
activity.26,39 Instead of copper and zinc, SOD-2 has manganese as its cofactor.39 SOD-3,
which was not examined in this study, is a SOD isoform generally found in the
extracellular space surrounding the cell.41 It provides extracellular antioxidant protection
against free radicals and plays a role in regulating signal transduction.41 SOD-3 is a
tetramer with a molecular weight of 135 kDa.40 Like SOD-1, it has one copper and one
zinc atom in each of its four subunits.40 Reactive oxygen species can also trigger genes
that promote cell survival, such as NF-κB, which will stimulate transcription of
antioxidant targets.42

NF-κB
Nuclear factor-κB is a ubiquitously expressed dimeric transcription factor that
regulates gene expression in a variety of different processes. These include the innate and
adaptive components of immunity, embryonic development, and the development and
functioning of the central nervous system, bones, skin, and mammary gland.43,44 In
inflammation, NF-κB increases transcription of cytokine and chemokine genes.44 The
transcription factor is also an important regulator of cell proliferation, apoptosis, and
stress responses to different harmful stimuli.45 NF-κB is also affected by AGE/RAGE
signaling. AGE/RAGE signaling has been shown to contribute to upregulation of NF-κB
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activity in nerve cells.46 Increases in activated NF-κB caused by AGE/RAGE signaling
promotes expression of cytokines that contribute to neuroinflammation.46 In addition to
its proinflammatory effects, NF-κB has also been shown to decrease oxidative injury
caused by reactive oxygen species by upregulating RAGE expression in pancreatic
cancer cells.19 There are five proteins in the NF-κB family, which include NF-κB1 (also
known as p50), NF-κB2 (also known as p52), ReLA (also known as p65), ReLB, and cReL. These individual proteins are able to dimerize with each other to form different
homodimers or heterodimers. NF-κB switches between active and inactive forms. When
inactive, NF-κB is sequestered in the cytoplasm by binding proteins called IκBs.47 NF-κB
is activated through two different signaling pathways. The first pathway is called the
canonical pathway. In the canonical pathway, extracellular ligands, which include
cytokines, mitogens, growth factors, and microbial antigens, bind to a variety of different
receptors to cause activation of IκB kinase (IKK).47 Activated IKK then phosphorylates
the sequestering IκB protein, which leads to the release of NF-κB.47 The NF-κB is then
able to translocate to the nucleus and exert its regulatory effects on gene expression. The
canonical and non-canonical pathways differ in terms of which NF-κB family member
they activate. The canonical pathway leads to the activation of the so-called canonical
members of the NF-κB family, which include NF-κB1, RELA, and c-REL.48 The noncanonical pathway activates the non-canonical members of the family, which include NFκB2 and RELB.48
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Figure 2: The AGE/RAGE Signaling Cascade. Hyperglycemic conditions result in a
heightened number of AGEs cross-linked to structural proteins in the ECM. These crosslinked AGEs bind to the transmembrane receptor RAGE to initiate the intracellular
signaling cascade. Downstream effects of the cascade include increased inflammation,
oxidative stress, fibrosis, and RAGE expression. Rap1a may play a role in regulation of
the AGE/RAGE cascade by allosterically interacting with the second-messenger proteins
that make up the pathway.

9

Rap1a
Rap1 is a low molecular weight GTPase that is a member of the Ras subfamily of
GTPases.49 It is a cytosolic protein that plays diverse roles, including regulation of cell
adhesion molecules, leukocyte extravasation, endothelial cell migration, and postnatal
angiogenesis.50-53 Rap1 is indirectly activated by a variety of different extracellular
stimuli, such as growth factors, neurotransmitters, and cytokines.50 These first
messengers activate Rap1 activity through the mediation of a number of different
intracellular second messengers, the most important of which is EPAC (exchange factor
directly activated by cAMP).50 Rap1 continuously switches between active and inactive
forms. In the active form, Rap1 is bound to the nucleotide GTP. In the inactive form,
Rap1 is bound to GDP. Rap1 is subject to regulation by other proteins, including GTPase
activating proteins (GAPs), which promote the inactive, GDP-bound form, and guanine
nucleotide exchange factors (GEFs), which promote the active, GTP-bound form. There
are two isoforms of the Rap1 protein, Rap1a and Rap1b. The two isoforms are
structurally very similar, sharing 95% amino acid sequence homology.49 The differences
in function of Rap1a and Rap1b are not well understood, but some studies suggest that
Rap1a may be important in maintaining junctions between cells, while Rap1b may
regulate changes to cell-cell junctions.54,55 We believe the Rap1a isozyme also plays an
important role as a bisector of the AGE/RAGE signaling cascade in cardiac fibroblasts. In
one study, inhibition of Rap1a expression appeared to lead to a decrease in activity of the
ζ isotype of protein kinase C, which is the first of a series of enzymes that make up the
AGE/RAGE signaling cascade.15 EPAC2-Rap1 signaling has also been shown to play an
important role in ventricular myocyte function. In one study, inhibiting this signaling led
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to arrhythmias in ventricular myocytes, due in part to a mechanism involving increased
reactive oxygen species production in the mitochondria.56

Summary
Several mechanisms at the cellular level contribute to diabetes-mediated heart
disease. One mechanism is the increase in AGE/RAGE signaling that occurs in diabetics
(Figure 3). Hyperglycemic conditions result in the formation of AGEs at an accelerated
rate. These AGEs form cross-links with structural proteins, particularly collagen, in the
extracellular matrix. AGE then binds with RAGE to initiate the AGE/RAGE signaling
cascade, ultimately causing an increase in inflammation, oxidative stress, fibrosis, and
RAGE expression. We believe the Rap1a GTPase may play a role in this signaling
cascade by interacting with the proteins that make up the pathway. Hyperglycemic
conditions also cause assembly of the NADPH oxidase system. This enzyme complex
catalyzes an oxidation-reduction reaction in which intracellular NADPH is oxidized
while molecular oxygen is reduced to form superoxide radicals. The superoxide radicals
then contribute to inflammation, oxidative stress, and fibrosis. Taken together, these
factors contribute to myocardial tissue dysfunction, resulting in heart disease.
There were several main goals with this project. The first goal was to determine
whether AGE/RAGE signaling would lead to a change in expression of the oxidative
stress markers p-NF-κB, SOD-1, and SOD-2 in cardiac fibroblasts of different genotypes.
Then, we wanted to see how increasing the level of AGE/RAGE signaling would affect
the relative expression of those proteins. Control of the level of AGE/RAGE signaling
was accomplished by growing cells on plates with different types of collagen, as well as
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adding EPAC to certain treatment groups. Another goal was to determine the role of
Rap1a in the AGE/RAGE signaling cascade. To accomplish this, expression levels of the
oxidative stress markers were measured in Rap1a wildtype and Rap1a knockout cells.

Figure 3: AGE/RAGE Signaling and NADPH Oxidase activity indirectly contribute
to diabetes-mediated heart disease. Hyperglycemic conditions result in increased
numbers of AGEs cross-linked to structural proteins in the ECM, as well as assembly of
the NADPH oxidase enzyme complex. These events indirectly contribute to diabetesmediated heart disease by promoting inflammation, oxidative stress, fibrosis, and RAGE
expression in the cells of the myocardium.
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CHAPTER II
METHODS
Animal Models
Diabetic Mouse Model (db/db)
Male type II diabetic mice (Leprdb/db) were used in this study. These mice have a
mutated copy of the gene that codes for the leptin receptor. Leptin is a hormone produced
by adipose cells that suppresses feelings of hunger.57 With this monogenic mouse model,
the leptin receptor gene has a point mutation at the 106th nucleotide in the gene.58
Normally, this nucleotide has a guanine nitrogenous base. After the mutation, the guanine
base is replaced with thymine.58 This point mutation results in a stop codon that
prematurely stops translation. This stop codon prevents the translation of the intracellular
domain of the leptin receptor, which is responsible for initiation of the signal transduction
cascade inside the cell.58 The result is a truncated, nonfunctional leptin receptor protein
that is unable to initiate signal transduction. Without a functional leptin receptor, leptin is
unable to exert its effects. As a result, mice cannot experience the usual satiating effects
of the endocrine signal and become obese.57

RAGE Knockout Mouse Model (RAGE-/-)
Male RAGE knockout mice (RAGE-/-; referred to as RKO throughout the rest of
the document) were used in this study. This mouse model was created by modifying the
RAGE gene. Sequences of DNA encoding the extracellular domain of RAGE were
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deleted by Cre-Lox recombination, and a reversely-oriented transcriptional EGFP
reporter gene was inserted into intron 1, and a neomycin cassette and a thymidine kinase
promoter were inserted into intron 7.59 After Cre exposure there was a global loss of
RAGE signaling in the mice.59 EGFP PCR genotyping reactions are performed as a
positive control for RAGE knockout mice.59 Heterozygous mice with one wild-type copy
of the RAGE gene (RAGE+/-) were then bred to create homozygous mice lacking a
functioning copy in either chromosome (RAGE-/-; RKO ).59 The lack of RAGE
expression results in the prevention of AGE/RAGE signaling. These RAGE knockout
mice were used to create diabetic RAGE knockout mice (db/dbRKO) and non-diabetic
RAGE knockout mice (db/wtRKO), by mating the RKO mice with heterozygous mice with
one wild-type leptin receptor (db/wt).

Rap1a Knockout Mouse Model (Rap1a-/-)
To study the impact of Rap1a on the AGE/RAGE signaling pathway, mice
lacking the Rap1a gene were used in this study. Rap1a knockout mice were created by
swapping the fourth exon of the Rap1a gene with a reversed antibiotic resistance gene
cassette in embryonic stem cells.60 These embryonic stem cells were then inserted into
early mouse embryos to create chimeric mice.60 The heterozygous chimeras were then
mated to form Rap1a knockout mice (Rap1a-/-) lacking an unmutated copy of the Rap1a
gene in either chromosome. These mice do not express the Rap1a protein as a result.60
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Animal Care
The experiments in this study were performed with 16-week-old male mice. The
mice were fed commercial mouse chow and given tap water ad libitum. The care of the
mice was in accordance with the principles established by the National Institutes of
Health “Guide for the Care and Use of Laboratory Animals” (NIH publication No. 85-12,
revised 1996). The University of Mississippi Animal Care and Use Committee approved
of the protocol (protocol #17-024) employed in these experiments. Before killing the
mice by dislocating the cervical vertebra, the mice were anesthetized via inhalation of
carbon dioxide. Shortly after death, the chest cavity was cut open, and the heart removed
for study.

Genotyping
Tail Digestion
Tail genotyping was used to identify the genotypes of mice. In the tail genotyping
procedure, tail segments a few millimeters in length were cut and placed in 1.5 mL
microcentrifuge tubes. The tubes were then filled with 250 µL of lysis buffer (50 mL
NaOH diluted in nuclease-free water). The tail segments were then broken up into small
pieces using scissors. The tubes were placed in a heat block at 95°C for 60 minutes. After
heating, the microcentrifuge tube was placed in a centrifuge and spun at 21,694 x g at
25°C for five minutes. The tubes were then removed from the centrifuge. 96.4 µL of
supernatant fluid was collected from each tube and placed in a separate tube containing 8
µL of 8 mM Tris-HCl buffer solution at pH 8.8.
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Db Genotyping
The polymerase chain reaction (PCR) technique was used to determine which
mice had the diabetic genotype. To each microcentrifuge tube, 29 µL of PCR master mix
were added. The ingredients of this master mix included 15 µL of 2X Dream Taq Hot
Start Mix (Thermo Fisher Scientific), 1 µL of Forward Primer (Db-F:
AGAACGGACACTCTTGAAGTCTC), 1 µL of Reverse Primer (Db-R2:
GGCCACAAAATATACACTTCTCTAATAAGCTC), and 12 µL of nuclease free water.
1 µL of sample containing DNA was then added to each microcentrifuge tube containing
master mix. Each tube containing DNA sample and master mix was then inserted into the
thermocycler (Applied Biosystems Pro-Flex Thermocycler). The following program was
executed by the thermocycler:
Table 1. Db Genotyping PCR Steps
Temperature
94℃
94℃
54℃
72℃
72℃
4℃

Time Cycles
5 min X 1
30 sec X 30
30 sec
30 sec
5 min X 1
Hold

After the first PCR run, the DNA was cleaned up by adding 50 µL of binding
buffer (Qiagen; Fermentas GeneJet PCR Purification Kit #K0702), 50 µL of isopropanol,
and 30 µL of the PCR product to chromatography columns. The chromatography
columns were then inserted into a 1.5 µL microcentrifuge tubes. The columns and tubes
were then spun for 1 minute at 12,000 x g in a centrifuge (Heraeus-Thermo Centrifuge).
After spinning, the flow-through was discarded. 700 µL of wash buffer (Qiagen;
Fermentas GeneJet PCR Purification Kit #K0702) was then pipetted into each column.
16

The columns and microcentrifuge tubes were then spun again for 1 minute at 12,000 x g.
After spinning, the flow through was discarded. The columns and microcentrifuge tube
were then spun once more to get rid of any remaining wash buffer. Following this, the
columns were inserted into new 1.5 mL microcentrifuge tubes. 50 µL of elution buffer
(Qiagen; Fermentas GeneJet PCR Purification Kit #K0702 were pipetted into each
column. The microcentrifuge tubes and columns were spun for 1 minute at 12,000 x g.
Following DNA clean-up, a second PCR run was executed. 29.5 µL of PCR
master mix were added to each PCR tube. This master mix included 15 µL of 2x Taq
Mix, 1 µL of Forward Primer (Db-F: AGAACGGACACTCTTGAAGTCTC), 1 µL of
Reverse Primer (Db-R1: CATTCAAACCATAGTTTAGGTTTGTGT), and 12.5 µL of
nuclease-free water. 2 µL of PCR product were added to each PCR tube containing
master mix. The PCR tubes containing master mix and DNA were then placed in the
thermocycler, which followed the same program outlined in Table 1 to carry out the
second PCR run.
After the second PCR run, DNA was digested by adding 1.5 µL of 10X Tango
Yellow Buffer (Thermo Fisher Scientific), 1.5 µL of RsaI (10 U/L, Thermo Fisher
Scientific), and 3.5 µL of nuclease-free water. 8.5 µL of the master mix was pipetted into
PCR tubes, along with 6.5 µL of PCR product. The PCR tubes were placed in the
thermocycler for 6 hours at 37℃.
Following this, a 3% agarose gel was made by adding 1.5 g of agarose (Thermo
Fisher Scientific) to 50 mL of Tris-Acetate-EDTA (TAE) (Thermo Fisher Scientific).
These ingredients were microwaved until the agarose dissolved in the 1X TAE. 8.5 µL
of ethidium bromide were then mixed with these ingredients. The mixture was then added
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to a gel electrophoresis tray, and a comb was inserted. The gel was then allowed to
solidify. After polymerization, 3 µL of dye was added to 15 µL of the PCR product. 17
µL of this mixture were then added to each well of the gel. In another well, 5 µL of dye
and 5 µL of ladder (Thermo Fisher Scientific) were added to create the ladder. This gel
was subjected to electrophoresis at 100 volts for 1 hour. The gel was then visualized, and
the bands present on the visualization indicated whether a mouse was a knockout (db/db)
diabetic, wild type (Db/Db), or heterozygous (Db/db) for the leptin receptor (Db). A band
at 187 bp on the gel indicated a wild type, a band at 135 indicated a knockout, and when
both 135 bp and 187 bp bands were present in a lane, that indicated a heterozygous
mouse.

Rap1a Genotyping
PCR was used to genotype Rap1a mice. To make the PCR master mix, 15 µL of
2X Dream Taq Hot Start Mix, 1 µL of ADPR266 (5 ́‐

TCTATCGCCTTCTTGACGAGTTC -3 ́), 2 µL of Rap1aKO ((5 ́‐

CTTGCTCTCCTGTTACCTATAGGTGCC -3 ́), and 12 µL of nuclease-free water were
added to each PCR tube. 2 µL of DNA sample were added to each PCR tube. PCR tubes
were then inserted into the thermocycler, programmed to carry out the following list of
steps.
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Table 2. Rap1a Genotyping PCR Steps
Temperature
93℃
93℃
57℃
65℃
65℃
4℃

Time
1.5 min
30 sec
30 sec
3 min
3 min
Hold

Cycles
X1
X 40

X1

After finishing the PCR run, a 2% agarose gel was created by adding 1 g of
agarose (Thermo Fisher Scientific) to 50 mL of TAE (Thermo Fisher Scientific). This
solution was microwaved until the agarose dissolved. 8.5 µL of ethidium bromide was
then added. The mixture was poured into a gel electrophoresis tray and a comb was
added. The gel was then allowed to solidify. 15 µL of each PCR product was then mixed
with 3 µL of dye. 17 µL of this mixture was then added to the wells of the gel. In one
well, 5 µL of dye and 5 µL of DNA ladder (Thermo Fisher Scientific) were added to
create the ladder. The gel was electrophoresed at 100 volts for 1 hour. The gel was then
visualized. Three genotypes were possible. If a lane corresponded to a Rap1a knockout
mouse (Rap1a-/- ), a band would be present at 1107 bp. If a lane corresponded to a Rap1a
wild type mouse (Rap1a+/+), a band at 1358 bp would be present. If there were bands at
1107 bp and 1358 bp, that corresponded with a mouse heterozygous for the Rap1a gene
(Rap1a+/-).

RAGE Genotyping
PCR was used to determine the genotype of mice with regards to the RAGE gene.
The master mix reagents included 15 µL of 2X Taq Mix, 1 µL of mRAGE e3-Forward
(5 ́‐CACAGGAAGAACTGAAGCTTGGAAGG -3 ́), 1 µL of mRAGE e5-Reverse (5 ́‐
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CACCTTTGCCATCGGGAATCAGAAG -3 ́), and 14 µL of RNA water. 29 µL of the
master mix were added to PCR tubes, along with 1 µL of DNA sample. The PCR tubes
were then added to the thermocycle, which carried out the following program:
Table 3. RAGE Genotyping PCR Steps
Temperature
94℃
94℃
54℃
72℃
72℃
4℃

Time Cycles
5 min X 1
30 sec X 30
30 sec
30 sec
5 min X 1
Hold

After finishing the PCR run, 1 g of agarose (Thermo Fisher Scientific) was added
to 50 mL of TAE (Thermo Fisher Scientific) to make a 1% agarose gel. This solution was
microwaved until the agarose dissolved. 8.5 µL of ethidium bromide were then added to
the agarose and 1X TAE, and the mixture was then added to a gel electrophoresis tray. A
comb was then added. The gel was then allowed to solidify. 15 µL of PCR products were
added to 3 µL of dye. 17 µL of the PCR product and dye were pipetted into each well of
the gel. To another well, 5 µL of DNA ladder and 5 µL of dye were added to create the
ladder. The gel was then electrophoresed at 100 volts for 20 minutes. The gel was then
visualized to determine the RAGE genotypes of the mice. If a lane corresponded to a wild
type mouse (RAGE+/+) or a heterozygous mouse (RAGE+/-), a band at 605 bp would be
present.
As an internal control, another genotype protocol was carried out with RAGE
mice, in order to detect whether a GFP (green fluorescent protein) fragment was inserted
into the Cre-loxP. If the GFP fragment was present, that indicated a RAGE knockout
mouse. For this PCR protocol, a master mix was created consisting of 15 µL of 2X Taq
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Mix, 1 µL of EGFP36-54 (5 ́‐GGTGCCCATCCTGGTCGAG -3 ́), 1 µL of EGFP346-

328 (5 ́‐

CGAACTTCACCTCGGCGCG -3 ́), and 14 µL of RNA water. 29 µL of this master mix
was then added to PCR tubes along with 1 µL of DNA sample. The PCR tubes were then
inserted into the thermocycler, which executed the following program.

Table 4. RAGE Genotyping PCR Steps #2
Temperature
94℃
94℃
56℃
72℃
72℃
4℃

Time
5 min
30 sec
30 sec
45 sec
10 min
Hold

Cycles
X1
X 35

X1

After finishing the PCR run, 1 g of agarose (Thermo Fisher Scientific) was added
to 50 mL of 1X TAE (Thermo Fisher Scientific) to generate a 1% agarose gel. This
solution was then microwaved until the agarose dissolved. After dissolution, 8.5 µL of
ethidium bromide was added. The solution was then poured into a gel electrophoresis
tray. A comb was added and the gel was allowed to solidify. 15 µL of PCR product were
mixed with 3 µL of dye, and 17 µL of this mixture were then added to the wells of the
gel. In one well 10 µL of dye and DNA ladder were added to create the ladder. The gel
was then subjected to electrophoresis at 100 volts for 30 minutes. The gel was then
visualized to determine the RAGE genotypes. If a lane corresponded to a RAGE
knockout mouse (RAGE-/-) or a heterozygous mouse (RAGE+/-), a band would be present
at 310 bp.
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Collagen Isolation and Immunohistochemistry
After euthanasia of the mice, tails from non-diabetic and diabetic mice were
collected and stored at −20°C. Once approximately 20 mouse tails of each genotype had
been collected, the tail skin was removed, and the four major tail tendons were teased
from the exposed tail, minced, washed in dH2O, and placed in 150 mL acetic acid
(1:1000 dilution in dH2O). The tendons were continually mixed for 72 hours at 4°C61.
After 3 days, the tendon-acetic acid solution was centrifuged at 3000 x g for 30 min at
4°C. The supernatant, containing the collagen, was removed to a new container, and the
supernatant was centrifuged again at 3000 x g for 30 min at 4°C. The collagen solution
was stored at 4°C until use. The collagen concentration was estimated using a
colorimetric assay called the SircolTM Soluble Collagen Assay Kit (BioColor Ltd.) as per
the manufacturer’s directions.
Preparations of extracted non-diabetic and diabetic collagen discs were made in
glass chamber slides and fixed with histology grade 4% paraformaldehyde for 10 minutes
at room temperature. Collagen was then incubated with blocking solution (3% donkey
serum, 2% BSA, and 0.01% Triton X-100 in 1× PBS) overnight in the refrigerator at 4°C.
After 24 hours, a primary antibody (AGE antibody (1:50; Abcam) and carboxymethyl
lysine (CML) antibody (1:50; Abcam)) were added to collagen onto the slides, which
were again incubated overnight in the refrigerator at 4°C. After incubation, slides were
rinsed, and fluorescently-tagged secondary antibodies (Abcam) were applied and allowed
to incubate for 1 hour at room temperature. Slides were mounted using Vectashield hard
set mounting media. Slides were visualized using a Nikon Eclipse Ti2 microscope with
pco.edge camera at 20X magnification.
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Fibroblast Isolation and Cell Culture
Mice were first anesthetized by exposing them to carbon dioxide. Following
inhalation of the CO2, the mice were killed by dislocating their cervical vertebrae. Mice
were then weighed and sterilized with 70% ethanol. The mice were then put on a mat for
dissection. Measurements of blood glucose levels were taken by first removing the tip of
the mouse's tail. A drop of the mouse’s blood was then reacted with a test strip. A blood
glucose meter (glucometer; OneTouch UltraⓇ, LifeScan, Inc., Johnson & Johnson) was
used to measure the concentration of glucose. Information about the heart and body
weights, as well as the blood glucose readings of the mice at different genotypes is
presented in Table 5.

After measuring the weights and blood glucose level, the chest of the mouse was
then cut open so that the heart could be removed and put in cold 1X non-sterile PBS
(phosphate buffered saline; 17 mM NaCl, 0.3 mM KCl, 1.01 mM Na2HPO4, 0.18 mM
KH2PO4, pH 7.4) on ice. For each fibroblast isolation, 2-3 heart were used for each
genotype. In a cell culture hood, the hearts were cut into pieces in a 60 mm petri dish.
The heart pieces were then washed using 1X sterile PBS three times. 5 mL of a
collagenase-trypsin enzymatic solution (0.1% Trypsin, Gibco; 100 U/mL collagenase II,
Worthington Biochemical) was then pipetted into the petri dish with the heart. The
contents of the petri dish were then added to a double-jacketed spinner flask that
contained a magnetic stir bar. Water was circulated through the flask continuously at
37℃. This mixture was allowed to stir for 10 minutes. The mixture was then strained into
a 50 mL conical tube with a 100 micrometer sterile disposable cell filter (Thermo Fisher
Scientific). Any tissue caught by the strainer was put back in the spinner flask. 5 mL of
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collagenase enzymatic mixture was added to the spinner flask. To the conical tube, 5 mL
of “Stop” medium (high glucose media; Dulbecco’s Modified Eagle's Medium (DMEM)
containing 4.5 g/L glucose, sodium pyruvate, L-glutamine, and supplemented with 14.2
mM NaHCO3, 14.9 mM HEPES, 30% heat-inactivated fetal bovine serum (FBS), 1% Lglutamine, and 0.02% Primocin (Thermo Fisher Scientific) was added. The tube was then
centrifuged for 10 minutes at 170 x g (Heraeus MegaFuge 8; Thermo Fisher Scientific).
The supernatant was then removed from the tube, leaving behind the cells pelleted at the
bottom of the tube. The pelleted cells were then resuspended in high-glucose DMEM
media containing 15% FBS. The cells were incubated at 37℃ until the fibroblast isolation
protocol was finished. This conical tube was the cell stock solution. Future cell harvests
were put in this stock suspension. The cycle was carried out several times until no more
heart tissue was present after straining. The stock solution with suspended cells was
centrifuged for 10 minutes at 170 x g. Cell suspension took place in high glucose DMEM
media. The cells were plated onto 60 mm petri dishes (one dish per heart) and, after 24
hours, the fibroblasts were washed with media three times. The cells were then placed in
an incubator at 37℃ in the media. Cardiac fibroblasts from diabetic mice were
maintained in a 15% FBS high glucose DMEM (4.5 g glucose/L). Non-diabetic cardiac
fibroblasts from wildtype and heterozygous mice were maintained in 15% low glucose
DMEM (1 g glucose/L). Experiments were performed on cells at P1, and cell type
determination was confirmed visually. Before reaching 95% confluency, cells were
passaged with a 0.25% trypsin, 0.1% ethylenediaminetetraacetic acid (trypsin/EDTA)
solution (Life Technology). The plates were maintained at 37℃ in a 5% CO2 incubator.
Cell culture media was replaced each day, until the cells were used for experiments.
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Cell Treatment
Collagen isolated from both non-diabetic and diabetic mouse tails was diluted 2:1
in acetic acid (diluted 1:1000), and then 100 µL of collagen solution was added to a
60mm dish. A sterile cell scraper was used to spread the collagen around the dish for
even coating. The collagen-coated dish was placed in the incubator for 1 hour at 37°C.
After an hour, the excess collagen was removed by washing twice with 1X sterile PBS.
Following the coating protocol, cells at P0 were split and plated on to dishes coated with
collagen. Once fibroblasts reached confluency, media was removed, cells were washed
with 1X PBS, and then starving media (DMEM containing 0.01% FBS) was added for 24
hours. After 24 hours, the starving media was replaced, and cells were allowed to rest for
1 hour, after which 150 µL of EPAC (100 µM; Sigma Aldrich) was added to the
appropriate dishes. Fibroblasts were incubated for 24 hours and then used for protein
isolation.
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Figure 4: Cardiac fibroblasts were isolated from mice and grown in three different
culture conditions. Cardiac fibroblasts isolated from mice were first plated on a plastic
dish. These cells were allowed to reach 90-95% confluency, then split into three types of
culture dish. In the first type, cardiac fibroblasts were grown on a plastic dish with no
underlying collagen. In the next type, fibroblasts were grown on a dish coated with nondiabetic collagen extracted from the tails of mice. In the final type, fibroblasts were
grown on diabetic collagen. The cells were then allowed to reach confluency. At that
point, the media was replaced with starving media (DMEM 0.01% FBS). After
incubating for 24 hours with the starving media, EPAC was added to specific plates. The
cells were then allowed to incubate for an additional 24 hours. After this incubation
period, protein was isolated from the cells.
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Protein Isolation
Protein was isolated from cells using modified hunter’s buffer (MHB; 1% Triton
X-100, 75 mM NaCl, 5 mM pH 7.4, 0.5 tris pH 7.4, 0.5 mM orthovanadate, 0.5 mM
ECTA, 0.5 mM EGTA, 0.25% NP-40, and freshly added Halt Protease Inhibitor Cocktail
(100X; Thermo Fisher)). Cells were incubated in 100 µL of MHB for 10 minutes on ice
followed by scraping cells from plates and probe-sonication. Samples were centrifuged
for 15 minutes at 32,000 x g at 4oC. Protein concentration was assessed using a
bicinchoninic acid assay (BCA; Pierce Biotechnology) according to manufacturer’s
instructions.

SDS-PAGE and Western Blotting
Separation of proteins in samples was accomplished by running 12 µg protein
samples on a 12% SDS-PAGE gel. To a gel, 7 µL of protein ladder containing protein
standards of known size was pipetted into the leftmost well. To the second well, a control
solution containing the supernatant from the lysis of an untreated mouse heart was added.
To the remaining 8 wells, 12 ug protein samples that had received different treatments
were added. The gel was then subjected to electrophoresis at 110 V for 2-3 hours, or until
good separation of proteins was achieved. After electrophoresis, the proteins on the gel
were transferred to a PVDF nitrocellulose membrane (Thermo Fisher Scientific) using
electrophoresis at 100 mA overnight. After transferring the proteins, the membrane was
washed with deionized water and stained using Coomassie blue dye (3 g Coomassie
Brilliant Blue, 45% methanol, 10% acetic acid, 45% diH2O) for 5 minutes. The
membrane was then destained 3-5 times (5 minutes per destain). The destaining process
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removed dye from every part of the membrane except for the proteins on the membrane.
A picture was then taken of the membrane to visualize the proteins using iBright CL1000
Imaging System (Invitrogen). After the picture, the membrane was washed five times
with 1X TBST (90% diH2O, 10% 10X TBS (500 mM Tris-Base, 1 M NaCl, 1 L diH2O,
pH 7.4), 0.1% Tween-20). After washing with TBST, a 5% milk (Carnation Nestle) or
BSA (Sigma Aldrich) blocking solution was applied to the membrane for one hour at
room temperature. A BSA blocking solution was added when probing membranes for
phosphorylated antibodies were used. A 5% milk or BSA solution containing primary
antibodies specific to the protein of interest (p-NF-κB, SOD-1, and SOD-2; Santa Cruz)
was then applied to the membrane in a 1:400 dilution. This membrane was then incubated
overnight at 4 °C. The next day, the primary antibody solution was removed from the
membrane. The membrane was then washed with 1X TBST 5 times at 5 minutes per
wash. A 1% milk solution containing secondary antibodies (1:750 dilution; Santa Cruz)
was then added to the membrane. The membrane was then incubated with this secondary
solution at room temperature for 1 hour with continuous rocking. The secondary solution
was then removed, and the membrane was washed with 1X TBST 5 times at 5 minutes
per wash. After washing with TBST, an ECL substrate solution (Pierce; Thermo Fisher
Scientific) was added to the membrane and incubated for 2 minutes while shaking. A
picture was then taken of the membrane to visualize the proteins of interest using the
iBright CL1000 Imaging System (Invitrogen).
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Statistical Analysis
Differences in expression of p-NF-κB, SOD-1, and SOD-2 among non-diabetic,
diabetic, non-diabetic RKO, and diabetic RKO fibroblasts grown on non-diabetic
collagen compared to cells of the same genotypes grown on a dish with no underlying
collagen (Figure 6) were calculated using a One-Way ANOVA followed by a Tukey’s
post-hoc. Differences in expression of p-NF-κB, SOD-1, and SOD-2 among Rap1a
wildtype and Rap1a KO grown on non-diabetic collagen compared to cells of the same
genotypes grown on a dish with no underlying collagen (Figure 8) were determined using
a Student’s t-test. Differences in expression of p-NF-κB, SOD-1, and SOD-2 among cells
of all genotypes as AGE/RAGE signaling was altered (Figures 10, 12, and 14) were
calculated by running a one-way ANOVA followed by a Dunnett’s post hoc. The control
group in the Dunnett’s post-hoc, to which other groups were compared, was set as
fibroblasts maintained on non-diabetic collagen. Major differences in body weight, heart
weight, and blood glucose levels of mice at different genotypes compared to non-diabetic
mice (Table 5) were determined by running a one-way ANOVA followed by a Dunnett’s
post hoc. In these experiments, p values less than 0.05 were considered significant. The
standard error of the mean (SEM) was shown by error bars on the graphs.
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CHAPTER III
RESULTS
Diabetic Mice Have Significantly Lower Heart Weight to Body Weight Ratios and
Significantly Higher Blood Glucose Levels
The body weights, heart weights, and blood glucose measurements were taken
shortly after euthanasia of the mice. We chose to present the heart weight to body weight
ratios as an estimate of animal obesity (Table 5). In previous studies it was found there
were no differences in heart weights between the genotypes; however, the body weights
of the diabetic animals were significantly greater than that of the non-diabetic mice.62 The
heart weight to body weight ratios were significantly lower in the diabetic animal groups
(i.e., diabetic and diabetic RKO) than that of non-diabetic mice. These findings strongly
indicate obesity. Additionally, there was a significant increase in blood glucose levels in
the diabetic and diabetic RKO mice.
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Heart Weight (mg)
Body Weight (g)

Blood Glucose
(mg/dL)

Non-Diabetic

3.764e-03 +/- 3.35e-004

198 +/- 30.22

Diabetic

2.14e-03 +/- 2.97e-004****

Non-Diabetic RKO

3.66e-03 +/- 3.03e-004

Diabetic RKO

2.21e-03 +/- 1.28e-004****

Rap1a WT

3.95e-03 +/- 3.33e-004

204 +/- 25.65

Rap1a KO

3.40e-03 +/- 3.83e-004

190.3 +/- 40.10

Genotype

497.1 +/- 128.1****
191.9 +/- 34.40
428.2 +/- 104.7****

Table 5. Significant differences in heart weight to body weight ratios and blood
glucose were observed in diabetic and diabetic RKO mice compared to non-diabetic
mice. One-way ANOVA followed by a Dunnett’s post hoc; p values < 0.05 were
considered significant. Data was presented as the mean + the standard error of the mean
(SEM).

Diabetic Collagen Has More AGEs and CMLs Than Non-Diabetic Collagen
Immunofluorescence staining was performed to qualitatively determine the level
of AGEs and AGE-derivatives, carboxymethyl lysine (CML), in collagen isolated from
non-diabetic and diabetic tail collagen, Figure 5. The punctate staining or bright spots
within the stained diabetic collagen indicated higher levels of AGEs and CMLs were
present. Thus, demonstrating that endogenous AGEs were more pronounced in the
diabetic collagen.
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Figure 5: Diabetic collagen has more AGEs and CMLs than non-diabetic collagen.
Immunofluorescence was used to detect AGEs and CMLs cross-linked to non-diabetic
and diabetic collagen. Bright spots indicate areas with extensive AGE or CML crosslinking. 20X magnification.
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Cardiac Fibroblasts Grown on Non-Diabetic Collagen Exhibited Differential
Expression of Inflammatory Markers
Fibroblasts isolated from both non-diabetic and diabetic mice had a significantly
higher level of phosphorylated-NF-κB (p-NF-κB) when grown on a non-diabetic collagen
substrate than cell grown on plastic (i.e., no collagen substrate), Figure 6A. Non-diabetic
and diabetic RKO cells had little to no change in p-NF-κB expression. In contrast,
expression levels of both SOD-1 and SOD-2 in non-diabetic and diabetic fibroblasts
cultured on non-diabetic collagen were significantly less than levels expressed in cells
grown on plastic, Figure 6B and 6C, respectively. Again, non-diabetic and diabetic RKO
fibroblasts had little to no change in SOD-1 or SOD-2 expression. Representative western
blot images for expression level of p-NF-κB, SOD-1, and SOD-2 for the experimental
groups are presented in Figure 7. Changes in protein expression were normalized to βTubulin.
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Figure 6: Cardiac fibroblasts grown on non-diabetic collagen exhibited differential
expression of inflammatory markers p-NF-κB, SOD-1, and SOD-2. A) Both non-db
and db fibroblasts grown on non-db collagen showed a significant increase in expression
of p-NF-κB compared to non-db and db fibroblasts grown on a dish with no underlying
collagen. Non-db RKO and db-RKO fibroblasts showed little change in p-NF-κB
expression. B-C) Non-db and db cardiac fibroblasts grown on non-db collagen expressed
significantly less SOD-1 and SOD-2 than cells grown on a dish with no underlying
collagen. Non-db and db RKO cells grown on non-db collagen showed little change in
expression of SOD-1 and SOD-2. The values for each column were calculated by
subtracting the protein expression level of fibroblasts grown on a plastic dish from the
protein expression level of fibroblasts grown on non-db collagen. A positive number
therefore indicates an increase in protein expression relative to cells grown on a plastic
dish, while a negative number indicates a decrease in expression. The statistical tests
conducted for these graphs included a One-Way ANOVA followed by a Tukey’s post hoc;
p values < 0.05 were considered significant. Data was presented as the mean + the standard
error of the mean (SEM)
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Figure 7: Representative western blot images of data presented in Figure 6. Changes
in protein expression were normalized to β-Tubulin.
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Rap1a KO Cardiac Fibroblasts Grown on Non-Diabetic Collagen Exhibited
Decreased Expression of Inflammatory Markers
Rap1a WT fibroblasts grown on non-diabetic collagen expressed more p-NF-κB
than Rap1a WT fibroblasts grown on a plastic dish with no underlying collagen matrix;
however, Rap1a KO cells grown on non-diabetic collagen expressed significantly less pNF-κB than Rap1a WT cells grown on non-diabetic collagen, Figure 8A. Rap1a WT
fibroblasts also expressed less SOD-1 and SOD-2 compared to the control group.
Additionally, Rap1a KO cells showed an even greater decrease in expression of SOD-1
and SOD-2 protein levels, Figure 8B and 8C. Representative western blot images for
expression level of p-NF-κB, SOD-1, and SOD-2 for the experimental groups are
provided in Figure 9.

Figure 8: Rap1a KO cardiac fibroblasts grown on non-diabetic collagen exhibited
decreased expression of inflammatory markers p-NF-κB, SOD-1, and SOD-2. A)
Rap1a WT fibroblasts grown on non-diabetic collagen expressed more p-NF-κB than
Rap1a WT fibroblasts grown on a plate with no underlying collagen. Rap1a KO cells
grown on non-diabetic collagen expressed significantly less p-NF-κB than Rap1a WT cells
grown on non-diabetic collagen. B-C) Rap1a WT fibroblasts expressed less SOD-1 and
SOD-2 compared to the control group. Rap1a KO cells showed an even greater decrease
in expression of SOD-1 and SOD-2. The statistical test conducted for these graphs was a
Student’s t-test; p values < 0.05 were considered significant. Data was presented as the
mean + the standard error of the mean (SEM).
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Figure 9: Representative western blot images of data presented in Figure 8. Changes
in protein expression were normalized to β-Tubulin.
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p-NF-κB Expression Increased with AGE/RAGE Signaling and Rap1a Activity
Growing both non-diabetic and diabetic cells on diabetic collagen with
endogenous AGEs resulted in significantly increased AGE/RAGE signaling as measured
by p-NF-κB protein expression. It was also found that increasing Rap1a activity with
EPAC led to significant increases in the expression of p-NF-κB in non-diabetic and
diabetic cardiac fibroblasts compared to cells on non-diabetic collagen not receiving
EPAC, Figure 10A and 10B. However, when treatments were combined (i.e., db collagen
+ EPAC) there was not a synergistic increase in p-NF-κB expression. Interestingly, nondb RKO and db-RKO fibroblasts showed little change in expression of p-NF-κB despite
increases in the number of environmental AGEs or treatment with EPAC, Figure 10C and
10D. Rap1a WT fibroblasts expressed significantly more p-NF-κB as AGE/RAGE
signaling and Rap1a activity were increased, Figure 10E. Lastly, Rap1a KO cells grown
on non-diabetic collagen that received EPAC showed little change in p-NF-κB expression
compared to the control. Rap1a KO cells grown on diabetic collagen with and without
EPAC stimulation did not significantly increase p-NF-κB expression, Figure 10F.
Representative western blot images for expression levels of p-NF-κB for the
experimental groups and genotypes are presented in Figure 11.
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Figure 10: p-NF-κB expression increased with AGE/RAGE signaling and Rap1a
activity. A-B) Increasing AGE/RAGE signaling by growing cells on diabetic collagen and
increasing Rap1a activity with EPAC led to significant increases in the expression of pNF-κB in non-diabetic and diabetic cardiac fibroblasts compared to cells on non-diabetic
collagen not receiving EPAC. C-D) Non-db RKO and db-RKO fibroblasts showed little
change in expression of p-NF-κB despite increases in the number of environmental AGEs
or treatment with EPAC. E) Rap1a WT fibroblasts expressed significantly more p-NF-κB
as AGE/RAGE signaling and Rap1a activity were increased. F) Rap1a KO cells grown on
non-diabetic collagen that received EPAC showed little change in p-NF-κB expression
compared to the control. Rap1a KO cells grown on diabetic collagen with and without
EPAC showed a modest increase in p-NF-κB expression. Statistical analysis: One-way
ANOVA followed by a Dunnett's post hoc. p values < 0.05 were considered significant.
Data was presented as the mean + the standard error of the mean (SEM).
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Figure 11: Representative western blot images of p-NF-κB (~65kDa) data presented
in Figure 10. Changes in protein expression were normalized to β-Tubulin.
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SOD-1 Expression Decreased With AGE/RAGE Signaling and Rap1a Activity
Increased AGE/RAGE signaling from exposure of cell to endogenous AGEs in
collagen from diabetic mice resulted in a decrease in SOD-1 expression. The addition of
EPAC to stimulate Rap1a led to decreased expression of SOD-1 by non-diabetic and
diabetic fibroblasts, relative to cells of the same genotypes grown on non-diabetic
collagen without EPAC treatment, Figure 12A and 12B. Exposure to endogenous AGEs
or treatment with EPAC did not affect either non-diabetic or diabetic RKO fibroblasts
SOD-1 expression, Figure 12C and 12D. Diabetic RKO fibroblasts showed a slight
decrease in expression of SOD-1 as the number of environmental AGEs increased and
upon addition of EPAC; however, these changes were not significant. Rap1a WT and
Rap1a KO fibroblasts exhibited significantly decreased SOD-1 expression relative to the
control in response to increased AGE/RAGE signaling, but addition of EPAC to Rap1a
KO cells had little effect on SOD-1 expression, Figure 12E and 12F. Representative
western blot images for expression levels of SOD-1 for the experimental groups and
genotypes are presented in Figure 13.
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Figure 12: SOD-1 expression decreased with AGE/RAGE signaling and Rap1a
activity. A-B) Increased AGE/RAGE signaling and addition of EPAC led to decreased
expression of SOD-1 by non-diabetic and diabetic fibroblasts, relative to cells of the same
genotypes grown on plastic without EPAC treatment. C) Non-db RKO fibroblasts showed
little change in SOD-1 expression when collagen type was changed or EPAC was added.
D) Diabetic RKO fibroblasts showed a decrease in expression of SOD-1 as the number of
environmental AGEs increased and upon addition of EPAC. E-F) Rap1a WT and Rap1a
KO fibroblasts exhibited a decrease in SOD-1 expression relative to the control in response
to increased AGE/RAGE signaling. Adding EPAC to Rap1a KO cells had little effect on
SOD-1 expression. Statistical analysis: One-way ANOVA followed by a Dunnett's post
hoc. p values < 0.05 were considered significant. Data was presented as the mean + the
standard error of the mean (SEM).
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Figure 13: Representative western blot images of SOD-1 (~21kDa) data presented in
Figure 12. Changes in protein expression were normalized to β-Tubulin.
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SOD-2 Expression Decreased With AGE/RAGE Signaling and Rap1a Activity
Increasing AGE/RAGE signaling by growing cells on diabetic collagen and/or
increasing Rap1a activity with EPAC addition led to a significant decrease in SOD-2
expression in non-diabetic and diabetic fibroblasts when compared to control cells,
Figure 14A and 14B. RKO cells grown on diabetic collagen with EPAC treatment
showed a slight increase in SOD-2 expression, Figure 14C and 14D. Diabetic RKO
fibroblasts showed a slight decrease in expression of SOD-2 as environmental AGEs and
EPAC were added; however, these changes were not significantly different. Figure 14E,
Rap1a WT fibroblasts showed a significant decrease in the expression of SOD-2 as
AGE/RAGE signaling, and this decrease became more pronounced when EPAC was
added. Rap1a KO fibroblasts showed a decrease in expression of SOD-2 as the number of
environmental AGEs increased. The addition of EPAC had no effect on the expression of
SOD-2 in Rap1a KO cells, Figure 14F. Representative western blot images for expression
levels of SOD-2 for the experimental groups and genotypes are presented in Figure 15.
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Figure 14: SOD-2 expression decreased with AGE/RAGE signaling and Rap1a
activity. A-B) Increasing AGE/RAGE signaling by growing cells on diabetic collagen and
increasing Rap1a activity with EPAC led to a significant decrease in SOD-2 expression in
non-diabetic and diabetic fibroblasts. C) Non-diabetic RKO fibroblasts grown on nondiabetic collagen with EPAC treatment showed little change in SOD-2 expression
compared to control cells. Non-diabetic RKO cells grown on diabetic collagen without
EPAC treatment showed little change in expression of SOD-2. Non-diabetic RKO cells
grown on diabetic collagen with EPAC treatment showed an increase in SOD-2 expression.
D) Diabetic RKO fibroblasts showed a decrease in expression of SOD-2 as environmental
AGEs and EPAC were added. E) Rap1a WT fibroblasts showed a significant decrease in
the expression of SOD-2 as AGE/RAGE signaling was increased and EPAC was added. F)
Rap1a KO fibroblasts showed a decrease in expression of SOD-2 as the number of
environmental AGEs increased. The addition of EPAC had no effect on the expression of
SOD-2 in Rap1a KO cells. All statistical tests consisted of running a one-way ANOVA
followed by a Dunnett's post hoc. p values < 0.05 were considered significant. Data was
presented as the mean + the standard error of the mean (SEM).
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Figure 15: Representative western blot images of SOD-2 (~26kDa) data presented in
Figure 14. Changes in protein expression were normalized to β-Tubulin.
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CHAPTER IV
DISCUSSION
The purpose of this study was to determine the impact of AGE/RAGE signaling
on oxidative stress in cardiac fibroblasts under diabetic conditions. Assessments of
oxidative stress were made by examining changes in the expression of several proteins
associated with oxidative stress, such as NF-κB, SOD-1, and SOD-2. Studies were
performed using cardiac fibroblasts from six different genotypes that were isolated from
mice and grown on plates that either had no underlying collagen (plastic), non-diabetic
collagen (low endogenous AGEs), or diabetic collagen (elevated endogenous AGEs).
Cells grown on plates with no underlying collagen had no environmental exposure to
AGEs, and therefore, no AGE/RAGE signaling occurred. Cells grown on plates with
underlying non-diabetic collagen had some exposure to environmental AGEs, due to
AGE-collagen crosslinking, and these cells possibly experienced some basal AGE/RAGE
signaling. Fibroblasts grown on plates with underlying diabetic collagen were exposed to
the greatest level of environmental AGEs due to the extensive AGE-collagen crosslinking
that can be seen in Figure 5. Cells of this group experienced the greatest amount of AGE
exposure and consequently an increase in RAGE signaling. We found that increasing the
number of environmental AGEs led to an increase in expression of p-NF-κB and a
decrease in expression of SOD-1 and SOD-2. Besides collagen type, the other
independent variable in this experiment was the presence or absence of EPAC, an
allosteric activator of Rap1a. Our lab has identified the Rap1a GTPase as a potential
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effector to modulate the downstream effects of the AGE/RAGE signaling pathway. The
activation of Rap1a by EPAC led to similar effects as AGE exposure, in that, increased
Rap1a activity led to an increase in p-NF-κB, and a decrease in expression of the
superoxide dismutases, SOD-1 and SOD-2. These results could provide further evidence
for Rap1a’s role as an augmenter of the AGE/RAGE signaling cascade.

Differences in Oxidative Stress Marker Expression Between Fibroblasts Grown
with No Underlying Collagen and Fibroblasts Grown on Non-Diabetic Collagen
It was first necessary to determine whether growing fibroblasts on non-diabetic
collagen would result in a change in oxidative stress marker expression. Non-diabetic and
diabetic fibroblasts were grown either on a plate with no underlying collagen (plastic), or
on a plate with non-diabetic collagen. On non-diabetic collagen, both non-diabetic and
diabetic cells expressed significantly more p-NF-κB and significantly less SOD-1 and
SOD-2 than cells grown on plastic. These results indicated that either the presence of
collagen, or the basal level of AGEs crosslinked to the collagen, were capable of causing
the observed changes in protein expression. To determine which factor was caused the
change, non-diabetic RKO and diabetic RKO fibroblasts were grown under the same set
of conditions with either underlying collagen or with no underlying collagen. Knocking
out the RAGE receptor in these cells would determine if changes in protein expression
were due to AGE/RAGE signaling or if the collagen alone altered cell behavior. If the
change in oxidative stress markers was an AGE-mediated response, there should have
been little to no difference in oxidative stress marker expression for RKO cells grown on
non-diabetic collagen compared to cells grown with no underlying collagen. This was
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indeed the case: non-diabetic RKO and diabetic RKO cells grown on non-diabetic
collagen showed little change in protein expression compared to cells grown on the
plastic dish. These results demonstrated that the differences in oxidative stress marker
expression were due to AGE/RAGE signaling, and not the collagen alone. Therefore,
growing cells on non-diabetic collagen led to differences in oxidative stress marker
expression, and those differences were due to AGE/RAGE signaling, not the presence of
collagen.

Rap1a WT and Rap1a KO Oxidative Stress Marker Expression
In this study, the effect of Rap1a on oxidative stress marker expression was also
studied. The presence of Rap1a, as a bisector of the AGE/RAGE signaling pathway,
would be expected to have an impact on oxidative stress marker expression, based on the
observations of oxidative stress marker expression found in this study. Several previous
studies have shown a link between Rap1 and oxidative stress. For example, one study on
ventricular myocytes found that inhibition of Rap1 led to an increase in ROS
production.56 However, we are unaware of prior studies that have examined the
expression of these specific oxidative stress markers under diabetic conditions in cardiac
fibroblasts. We found when Rap1a WT and Rap1a KO fibroblasts were grown on plates
either with no underlying collagen or non-diabetic collagen, Rap1a KO cells plated on
non-diabetic collagen expressed significantly less p-NF-κB, SOD-1, and SOD-2 than
Rap1a WT cells grown on non-diabetic collagen. These findings provide evidence that
Rap1a plays an important role in regulating the downstream effects of the oxidative
pathway mediated by the AGE/RAGE cascade. Curiously, Rap1a KO cells plated on non-
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diabetic collagen expressed significantly less p-NF-κB than Rap1a KO cells plated on a
plastic dish. This finding is opposite of what we would expect. Due to the presence of
AGE/RAGE signaling, Rap1a KO cells plated on non-diabetic collagen should express
more p-NF-κB than Rap1a KO cells plated on a plastic dish similar to that of nondiabetic cells. Instead, the opposite result was observed. Likewise, Rap1a KO cells plated
on non-diabetic collagen expressed significantly less SOD-1 and SOD-2 than Rap1a WT
cells plated on non-diabetic collagen. We would expect that the WT cells should express
fewer of the dismutase enzymes than the KO cells, based on the trend that increasing
AGE/RAGE signaling decreases SOD-1 and SOD-2 production. Instead the opposite
result was observed. These results indicate that Rap1a does not appear to simply increase
the downstream effects of the AGE/RAGE signaling cascade in all cases. There may be a
level of differential expression occurring based upon concentration of environmental
AGE exposure and level of RAGE activation to be explored in future studies.

Oxidative Stress Marker Expression and AGE/RAGE Signaling
After determining that AGE/RAGE signaling has an effect on oxidative stress
marker expression, the next step was to determine if increasing the level of AGE/RAGE
signaling would affect the expression levels of p-NF-κB and the SODs. AGE/RAGE
signaling was increased either by growing cells on different types of collagen (e.g.,
diabetic vs. non-diabetic collagen), adding EPAC to increase Rap1a activity, or through a
combination of these variables. Non-diabetic and diabetic cardiac fibroblasts exhibited an
increase in expression of p-NF-κB as AGE/RAGE signaling was increased. Non-diabetic
RKO and diabetic RKO fibroblasts showed no significant change in p-NF-κB expression
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as the number of environmental AGEs increased or when EPAC was added. Rap1a WT
fibroblasts demonstrated a significant increase in p-NF-κB as AGE/RAGE signaling was
increased similar to that of non-diabetic cells. Rap1a KO fibroblasts grown on nondiabetic collagen showed little change in p-NF-κB expression, and when EPAC was
added, due to the lack of EPAC-Rap1a interaction in those cells, p-NF-κB did not
significantly change. Rap1a KO fibroblasts grown on diabetic collagen showed a slight
increase in p-NF-κB expression with and without EPAC; however, the results did not
significantly differ from controls. Collectively, these results indicate the importance of
Rap1a in determining downstream AGE/RAGE signaling outcomes.
The effects of increasing AGE/RAGE signaling on superoxide dismutase
expression was studied as well. Our results indicate increasing AGE/RAGE signaling led
to a decrease in superoxide dismutase expression in non-diabetic and diabetic cardiac
fibroblasts. In non-diabetic and diabetic RKO cells, increasing the amount of
environmental AGEs or adding EPAC had no significant effect on either SOD-1 or SOD2 expression. In Rap1a WT fibroblasts, increasing the number of AGEs in the
environment led to a decrease in expression of the SODs similar to that of non-diabetic
cells. Likewise, in Rap1a KO fibroblasts, increasing the number of AGEs in the
environment led to a decrease in the expression of the SODs; however, adding EPAC to
Rap1a KO fibroblasts did not lead to a significant change in superoxide dismutase
expression beyond levels affected by AGE/RAGE signaling.
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Conclusion
In this study, the impact of AGE/RAGE signaling on oxidative stress in cardiac
fibroblasts under diabetic conditions was studied. We found that AGE/RAGE signaling
plays an important role in the expression of the oxidative stress markers p-NF-κB, SOD1, and SOD-2 by cardiac fibroblasts. Increasing AGE/RAGE signaling led to an increase
in expression of p-NF-κB and a decrease in expression of the SODs. In addition, this
study appears to provide further evidence for the important role that Rap1a plays as a
bisector of the AGE/RAGE axis. Activation of Rap1a by EPAC led to significant
increases in expression of p-NF-κB and significant decreases in the expression of the
SODs. These results indicate Rap1a’s importance as an augmenter of the AGE/RAGE
signaling cascade.
Oxidative stress is a phenomenon with major clinical significance. Chronic
hyperglycemia is strongly linked to myocardial damage caused by oxidative stress.63,64 In
cardiac myocytes, this oxidative stress is primarily the result of the electron transport
chain and NADPH oxidase activity.65 SOD-1 and SOD-2 therefore have important
cardioprotective roles, as they are responsible for the neutralization of superoxide radicals
that would otherwise contribute to oxidative stress. The significant decrease in
superoxide dismutase expression due to AGE/RAGE signaling observed in this study
could provide an additional explanation for why oxidative damage occurs in the cells of
diabetics - with fewer dismutase enzymes available to dismantle free radicals generated
by hyperglycemia, increased AGE/RAGE-related signaling, and NADPH oxidase activity
- it is likely that an exceedingly high level of oxidative stress will occur.
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The increase in p-NF-κB expression could also promote oxidative stress in the
cardiac fibroblast. In one study, AGE/RAGE signaling was shown to cause upregulation
of NF- κB activity in nerve cells.46 This increase in NF- κB activity led to the increase in
expression of cytokines that contribute to neuroinflammation.46 In another study,
treatment of type 2 diabetic mice with NF- κB blockers attenuated oxidative stress by
downregulating mitochondrial free-radicals. Downregulation of NF- κB activity helped
maintain mitochondrial structural integrity and helped restore cardiac function.66 Whether
these proinflammatory effects of NF- κB are generalizable to AGE/RAGE-mediated NFκB activity in diabetic cardiac fibroblasts will require further study. If AGE/RAGEmediated NF- κB activity indeed leads to an increase in oxidative stress and cardiac
dysfunction, this signaling cascade may represent a potential drug target for the treatment
or prevention of diabetes-mediated heart disease. In order to determine exactly what
effect AGE/RAGE signaling has on levels of ROS in diabetic cardiac fibroblasts, future
studies may include measuring directly whether reactive oxygen species production
increases with increased AGE/RAGE signaling. This would provide more insight into
how disruptive AGE/RAGE signaling is to normal cellular mechanisms that prevent
oxidative stress.
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